About the Pilot
Personalised Medicine (PM) is strongly technological driven and will induce a transformation of how health and well-being are approached, and medicine is being implemented The convergence of knowledge on what determines health and disease or how the process of ageing is determined, with digital technologies and access to data opens a huge potential to develop new applications to improve general health secure the sustainability of our healthcare systems.
PM developments are impacting virtually all domains of modern medicine. Approaches building on the latest insights on the biological functioning of single cells is currently among the most promising areas. One of the key factors for the successful implementation of PM is the availability of standardised, accessible, processed data, which also enables the re-use of publicly available data for exploring multidisciplinary research goals. Next to access to and gathering data, the availability of a highly qualified biomedical and healthcare workforce to generate, analyze and process PM data to translate data into new products and applications is an essential requirement.
Activities & Long Term Goals
The pilot aims at realising the potential of personalised medicine as part of the S3 platforms on Industrial Modernisation. This pilot will bring the agenda to implement personalised medicine to the next level while transforming the connected European industrial value chains. The partner regions already established solid ecosystems combining biomedical, technological and data-driven expertise. By bringing these ecosystems together, a higher added value will be reached and boost the implementation of personalised medicine; it will realise an innovative approach for health and care in Europe.
The pilot is active in the four phases of the methodology. After the initial scoping, the network has been established as a learning- and co-creation community, which exchanges knowledge on a regular basis by organising tailormade workshops and connecting the different regional stakeholders in events or digital seminars. This connection is based on the quadruple helix; involving stakeholders from research & innovation, businesses and field labs, regional and local governments, hospitals and healthcare centers as well as clients and citizens. Demo-cases will be brought forth by partner regions. After an initial presentation of the demo-case proposal, complementary expertise will be assessed. A GAP- and SWOT-analysis will highlight the knowledge that needs to be added to the project and identify the pilot partners best suited to take up the role in question. The demonstration phase will entail the operation of large-scale interregional pilots based on the four objectives. This implementation in the regions will enable the last phase of commercialisation of new products and services by the private sector